Cargando…
Clinical Translation of Long-Acting Drug Delivery Systems for Posterior Capsule Opacification Prophylaxis
Posterior capsule opacification (PCO) remains the most common cause of vision loss post cataract surgery. The clinical management of PCO formation is limited to either physical impedance of residual lens epithelial cells (LECs) by implantation of specially designed intraocular lenses (IOL) or laser...
Autores principales: | Li, Xinyang, Liang, Chen, Guo, Yexuan, Su, Jing, Chen, Xi, Macgregor, Robert B., Zhang, Rui Xue, Yan, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10143098/ https://www.ncbi.nlm.nih.gov/pubmed/37111720 http://dx.doi.org/10.3390/pharmaceutics15041235 |
Ejemplares similares
-
Prophylaxis of posterior capsule opacification through autophagy activation with indomethacin-eluting intraocular lens
por: Zhang, Xiaobo, et al.
Publicado: (2022) -
Posterior Capsule Opacification: A Review of Experimental Studies
por: Konopińska, Joanna, et al.
Publicado: (2021) -
Risk factors for the occurrence of visual-threatening posterior capsule opacification
por: Chen, Hung-Chi, et al.
Publicado: (2019) -
Research Progress of Drug Prophylaxis for Lens Capsule Opacification after Cataract Surgery
por: Zhang, Rong-Pei, et al.
Publicado: (2020) -
Further Enhancement of Intraocular Open-Capsule Devices for Prevention of Posterior Capsule Opacification
por: Slutzky, Lee, et al.
Publicado: (2018)